TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Panadact Life Science AB
Closing information (x1000 SEK)
| Closing information | 2022/12 | 2021/12 | 2020/12 |
| Turnover |
1,347
|
1,026
|
1,115 |
| Financial expenses |
1
|
1
|
1 |
| Earnings before taxes |
515
|
614
|
164 |
| EBITDA |
317
|
-64
|
156 |
| Total assets |
2,063
|
1,692
|
997 |
| Current assets |
1,454
|
1,203
|
536 |
| Current liabilities |
1,050
|
637
|
267 |
| Equity capital |
647
|
830
|
614 |
| - share capital |
50
|
50
|
50 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2022/12 | 2021/12 | 2020/12 |
| Solvency |
31.4%
|
49.1%
|
61.6% |
| Turnover per employee |
1,347
|
1,026
|
1,115 |
| Profit as a percentage of turnover |
38.2%
|
59.8%
|
14.7% |
| Return on assets (ROA) |
25.0%
|
36.3%
|
16.5% |
| Current ratio |
138.5%
|
188.9%
|
200.7% |
| Return on equity (ROE) |
79.6%
|
74.0%
|
26.7% |
| Change turnover |
321
|
-89
|
106 |
| Change turnover % |
31%
|
-8%
|
11% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2022/12 | 2021/12 | 2020/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.